Literature DB >> 17467700

ERp57 interacts with conserved cysteine residues in the MHC class I peptide-binding groove.

Antony N Antoniou1, Susana G Santos, Elaine C Campbell, Sarah Lynch, Fernando A Arosa, Simon J Powis.   

Abstract

The oxidoreductase ERp57 is a component of the major histocompatibility complex (MHC) class I peptide-loading complex. ERp57 can interact directly with MHC class I molecules, however, little is known about which of the cysteine residues within the MHC class I molecule are relevant to this interaction. MHC class I molecules possess conserved disulfide bonds between cysteines 101-164, and 203-259 in the peptide-binding and alpha3 domain, respectively. By studying a series of mutants of these conserved residues, we demonstrate that ERp57 predominantly associates with cysteine residues in the peptide-binding domain, thus indicating ERp57 has direct access to the peptide-binding groove of MHC class I molecules during assembly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467700     DOI: 10.1016/j.febslet.2007.04.034

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  The effect of PDIA3 gene knockout on the mucosal immune function in IBS rats.

Authors:  Zhao-Meng Zhuang; Xiao-Teng Wang; Lu Zhang; Li-Yuan Tao; Bin Lv
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.

Authors:  Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2008-02-18       Impact factor: 7.397

3.  Impact of beta 2-microglobulin on tapasin expression and covalent association.

Authors:  Laura C Simone; Brittney L Smith; Joyce C Solheim
Journal:  Cell Immunol       Date:  2012-10-01       Impact factor: 4.868

4.  PDIA3 gene induces visceral hypersensitivity in rats with irritable bowel syndrome through the dendritic cell-mediated activation of T cells.

Authors:  Zhaomeng Zhuang; Lu Zhang; Xiaoteng Wang; Liyuan Tao; Bin Lv
Journal:  PeerJ       Date:  2016-11-17       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.